Structure Therapeutics (GPCR) Other Gross PP&E Adjustments (2022 - 2026)
Quarterly Other Gross PP&E Adjustments fell 17.98% to -$12.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$12.8 million through Mar 2026, down 17.98% year-over-year, with the annual reading at -$1.1 million for FY2025, 18.37% up from the prior year.
Structure Therapeutics' Other Gross PP&E Adjustments history spans 5 years, with the latest figure at -$12.8 million for Q1 2026.
- Other Gross PP&E Adjustments came in at -$12.8 million for Q1 2026, down from -$1.1 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $805000.0 in Q4 2022 to a low of -$12.8 million in Q1 2026.
- The 5-year median for Other Gross PP&E Adjustments is -$4.0 million (2023), against an average of -$4.5 million.
- The largest YoY upside for Other Gross PP&E Adjustments was 65.64% in 2024 against a maximum downside of 1208.04% in 2024.
- Structure Therapeutics' Other Gross PP&E Adjustments stood at $805000.0 in 2022, then plummeted by 584.1% to -$3.9 million in 2023, then soared by 65.64% to -$1.3 million in 2024, then increased by 18.37% to -$1.1 million in 2025, then crashed by 1070.91% to -$12.8 million in 2026.
- Per Business Quant, the three most recent readings for GPCR's Other Gross PP&E Adjustments are -$12.8 million (Q1 2026), -$1.1 million (Q4 2025), and -$10.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | -12.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.80 Mn |
| Mar 31, 2026 | -12.80 Mn |
| Dec 31, 2025 | -1.09 Mn |
| Dec 31, 2025 | -1.09 Mn |
| Sep 30, 2025 | -9.99 Mn |
| Sep 30, 2025 | -9.99 Mn |
| Jun 30, 2025 | -10.37 Mn |
| Jun 30, 2025 | -10.37 Mn |
| Mar 31, 2025 | -10.85 Mn |
| Mar 31, 2025 | -10.85 Mn |
| Dec 31, 2024 | -1.34 Mn |
| Dec 31, 2024 | -1.34 Mn |
| Sep 30, 2024 | -2.51 Mn |
| Sep 30, 2024 | -2.51 Mn |
| Jun 30, 2024 | -4.01 Mn |
| Jun 30, 2024 | -4.01 Mn |
| Mar 31, 2024 | -4.41 Mn |
| Mar 31, 2024 | -4.41 Mn |
| Dec 31, 2023 | -3.90 Mn |
| Dec 31, 2023 | -3.90 Mn |
| Sep 30, 2023 | -4.07 Mn |
| Sep 30, 2023 | -4.07 Mn |
| Jun 30, 2023 | 433,000.00 |
| Jun 30, 2023 | 433,000.00 |
| Mar 31, 2023 | 398,000.00 |
| Mar 31, 2023 | 398,000.00 |
| Dec 31, 2022 | 805,000.00 |
| Dec 31, 2022 | 805,000.00 |